Biomatter Designs Company
Pioneering the technologies for generative protein design at the intersection of synthetic biology and AI.
Founded Date:
2018-01-01
Technology:
Artificial Intelligence, Biotechnology, Pharmaceutical
Funding Status:
Seed
Total Funding:
608000.0
Employee Number:
11-50
Headquarters:
Vilnius, Vilniaus Apskritis, Lithuania
Last Funding Date:
2021-01-11
Investors Number:
2.0
Last Funding Type:
Seed
Industry:
Early Drug Development